IRX-2
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for IRX-2, covering 2012-02-08 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer [Phase 1]